ABSTRACT Our studies revealed that dissociated cells from medaka (the fresh-water fish, Oryzias latipes) blastula-stage embryos differentiate into many rhythmically contracting cells when incubated with a conditioned medium from a cell line. Analyses of these cells by immunostaining, electron microscopy, expression of marker genes, action potential recordings and pharmacological responses all showed the characteristics of myocardial cells. We succeeded in purifying the cardiac cell-inducing factor from the conditioned medium by 523,100-fold with 8% recovery of the protein. Analysis of its amino-acid sequence by mass spectrometry revealed the factor to be medaka activin A 2 (homodimer of inhibin β β β β βA 2 subunit). Recombinant human activin A showed the same cardiac cell-inducing activity toward medaka embryonic cells. Our results demonstrate that activin A is a potent factor for medaka myocardial cell differentiation. This culture method should provide a novel and simple experimental system to study cardiomyocyte differentiation in vitro.
Introduction
Pluripotent embryonic stem (ES) cell lines have been established from the inner cell masses of early human (Thomson et al., 1998) or other mammalian embryos and are expected to provide a unique system for tissue engineering. The technology to induce pluripotent stem cells (the iPS cells) from cultured mouse (Takahashi and Yamanaka, 2006) or human (Takahashi et al., 2007) somatic cells has recently been developed. Thus it will be possible to create pluripotent cells directly from somatic cells of patients. Differentiation of ES or iPS cells into cardiomyocytes has been demonstrated (Kehat et al., 2001; Xu et al., 2002; Passier et al., 2005; Denning et al., 2006; Laflamme et al., 2007; Takahashi et al., 2007) . Attempts to treat heart disease using these cells have been carried out and transplantation of human ES cell-derived cardiomyocytes to infarcted hearts of athymic rat or mouse was shown to improve heart function (Laflamme et al., 2007; van Laakea et al., 2007) . While these methods are expected to be used in regenerative cell therapy for treatment of human heart disease, more detailed studies are required for a better understanding of the molecular mechanisms of early cardiac differentiation, proliferation and maturation of the induced cardiomyocytes.
The protocol for in vitro induction of the cardiomyocytes was based on the results of experiments using animal models such as amphibians and chicken. Experiments with tissue fragments from embryos of these animals revealed that cardiac myogenesis is regulated by several temporally and spatially distinct signaling events. Although participation of many protein factors has been reported in cardiogenesis including activin, bone morphogenetic proteins (BMPs), or fibroblast growth factors (FGFs) (Lough and Sugi, 2000; Yutzey and Kirby, 2002; Zaffran and Frasch, 2002; Brand, 2003; Fukuda and Yuasa, 2006) , the primary mechanisms underlying cardiac induction, especially which signal initiates specification, have yet to be fully characterized. In chicken embryos, there seem to be distinct mechanisms between the cardiac cell-inducing activities of early stage hypoblasts and those of late stage antero-lateral (AL) endo-derm where hypoblast-derived signals (activin) act upstream of the heart-inducing signals provided by AL endoderm (BMPs and FGFs) (Sugi and Lough, 1995; Schultheiss et al., 1995; Lough et al., 1996; Yatskievych et al., 1997; Ladd et al., 1998; Barron et al., 2000) . In frog embryos, induced differentiation of animal cap cells into cardiomyocytes in vitro was shown after treatment with activin (Ariizumi et al., 1996; Ariizumi et al., 2003) .
Small fresh-water fish such as medaka (Oryzias latipes) and zebrafish (Danio rerio) are attracting increasing interest as animal models for research in vertebrate development. We have been using pluripotent cells isolated from early stage medaka embryos for cell culture experiments (Hyodo et al., 1998) . Medaka produces considerable numbers of eggs daily under conditions of controlled water temperature and light periods. The eggs are relatively large (about 1 mm in diameter) and transparent so that they can be easily observed or manipulated under low magnification microscopy. The recent release of a draft genome sequence for medaka should facilitate research in many fields (Kasahara et al., 2007) . Although attempts to establish ES cells from fish embryos have been reported (Hong et al., 1998; Fan and Collodi, 2006) , success remains limited. Furthermore, there have been no reports of studies employing in vitro fish cell culture to investigate the induction of cardiomyocytes. During our study to culture medaka embryonic cells, we found that a conditioned medium prepared with a medaka cell line effectively induces cardiogenesis in vitro. We report here the purification and identification of the protein factor responsible for this induction. The factor was found to be medaka activin A 2 . Human activin A was also shown to have cardiac cell-inducing activity in this new experimental system.
Results

Induction of rhythmically contracting cells from medaka embryonic cells
While we were attempting to establish ES cells from medaka embryos (Hyodo et al., 1998) , we tested the effect of the conditioned medium. The conditioned media were prepared from 6 medaka fibroblast cell lines established independently in our laboratory. They were added to cultures of dissociated cells prepared from the blastula-stage medaka embryos. Then we found that one of them (CM-1) induced spontaneously contracting cells after several days of incubation. Differentiation occurred in primary cultures in which most of the cells were growing as a monolayer. At first, we examined the dose-dependent effects of CM-1 and the results are shown in Fig. 1 . For determination of cardiac cell-inducing activity, the contracting loci (groups of cardiomyocytes) were counted under a microscope after 5 days of incubation. The results show that the differentiation of contracting cells was dependent on CM-1. Without the addition of CM-1, contracting cells were almost never observed. When 10-20 µl of CM-1 was added to the culture, cell growth was promoted and lower level of cardiac differentiation was observed. Then a maximum number of contracting locus was found when 40 µl of CM-1 was added to a 1.2 ml culture. Under the same conditions, A cell number decreased to about 50% of the maximum. When increasing the amount of CM-1 to more than 40 µl/well, extensive cell death occurred so that both the cell number and yield of contracting loci decreased. These results show that differentiation occurred within a narrow concentration range of a factor contained in CM-1. Fig. 2 shows a typical result of microscopic observation of cultured medaka embryonic cells. At first, blastoderms were excised from blastula-stage embryos, and blastomeres were dissociated into single cells ( Fig. 2A) . Cells were then incubated in 1.2 ml of 199ES2 medium containing 40 µl CM-1, the most suitable conditions for differentiation of the contracting cells. After 1 day of incubation, many colonies of epithelial cells were observed (Fig. 2B) . The cells were small and each cell contained a large nucleus and a small amount of cytoplasm. At the center of colonies, cells were tightly associated with each other so that the cell boundaries were not clear. Their appearance was similar to those of mammalian ES cells. After incubation for 2 days, some cells at the center of these colonies died and degraded (Fig. 2C) . Many of the surviving cells were found to differentiate into rhythmically contracting cells. The cells started beating after incubation for 2-3 days. This beating was weak and irregular at first, but it became regular and strong after 4 days of incubation. In intact embryos, heart contractions started at approximately the same time (Iwamatsu, 2004) as those in the in vitro culture system. Fig. 2D shows groups of contracting loci incubated for 6 days. Contracting cells are also shown in the online data supplements (Movie 1). The pulse rate was approximately 100-110/min at 28 o C, and this was similar to those of intact embryonic heart. Such rhythmical contractions continued for more than 2 months with weekly medium changes.
Characterization of rhythmically contracting cells
To characterize these rhythmically contracting cells, the expression of a cardiac troponin I in cultured cells was investigated by immuno-staining with a monoclonal antibody. As shown in Fig. 2E , the contracting loci were positively stained with the anti-cardiac troponin I antibody. Among cells incubated without CM-1, no contracting cells formed and cells were not stained with the monoclonal antibody (data not shown). Fig. 2F shows a result of ultrastructural analysis of embryonic cellderived beating cells incubated for 14 days. The electron micrograph shows sarcomeric organization with Z-bands and intercalated discs. Thus, the results of immunohistochemical and ultrastructural analyses indicated that the spontaneously contracting cells displayed characteristics of cardiomyocytes. Fig. 3 shows the results of gene expression analysis by RT-PCR. The expression levels of four cardiac-specific genes, including Nkx2.5 (cardiac specific homeobox gene), amhc (atrium myosin heavy chain), mhc1 (myosin heavy chain 1), cmlc2 (cardiac myosin light chain 2), as well as EF-1α (elongation factor 1α) as a control, were examined. The results show that expression of the cardiac specific genes can be detected after incubation in CM-1 for 3 days and continues for at least 4 weeks.
An electrophysiological study was carried out on the contracting cells after 2 weeks of incubation in CM-1 (Fig. 4) . A cardiomyocyte-like action potential was recorded from these spontaneously beating cells and shows the following properties: (1) a relatively long action potential duration or plateau; (2) a relatively shallow resting membrane potential; and (3) a pacemaker-like late diastolic slow depolarization. They revealed a sinus node-like action potential rather than action potentials like those of matured ventricular cardiomyocytes. These results confirmed that the contracting cells were cardiomyocytes.
Pharmacological responses of the contracting cells
To further characterize the properties of differentiated cardiomyocytes derived from medaka embryonic cells, their pharmacological responses were examined. For this purpose, cardiomyocytes were incubated with various concentrations of drugs and their beating frequencies were measured. The contracting cells were treated with phenylephrine (an α 1 -adrenergic receptor agonist; Fig. 5A ), or isoproterenol (a β 1 -adrenergic receptor agonist; Fig. 5B ). Both of these drugs enhanced contraction rate in a dose-dependent manner. Clenbuterol (a β 2 -adrenergic receptor agonist; Fig. 5C ) caused slight increases in the beating rate. Fig. 5D shows that the beating frequency was decreased by diltiazem (a calcium channel blocker) in a concentration-dependent manner and that treatment of cells with 10 -7 M diltiazem stopped contractions completely. These results show that differentiated cardiomyocytes responded to adrenergic agonists and Ca 2+ blockers similarly to those in vivo.
Purification and identification of the cardiac cell-inducing factor
To purify the cardiac cell-inducing factor from the conditioned medium, fractionation steps employing ammonium sulfate, SPSephadex, Sephadex G-75, hydroxyapatite and SP-Sepharose columns were performed. For determination of cardiac cellinducing activity during these steps, one unit was defined as the The rhythmically contracting cells were positively stained with the anti-cardiac troponin I antibody (Fig. 8) . And RT-PCR experiments revealed that expression of the cardiac specific genes can also be detected (Fig. 9) . These results confirm that activin A is a potent inducer of myocardial cells from medaka embryonic cells.
Discussion
Differentiation of cardiomyocytes in vitro
We found that when dissociated cells isolated from the medaka blastula-stage embryos were incubated with the conditioned fects of the purified medaka activin A2 on the dissociated embryonic cells. The results are similar to those with CM-1 (Fig. 1) .
Human activin A can induce medaka cardiac myocytes
We next examined whether human activin A (78% identity to medaka activin A 2 in amino-acid sequence) possesses the same cardiac cell-inducing activity towards medaka embryonic cells. The results are shown in Fig. 7B and indicate that recombinant human activin A has the same activity as medaka activin A 2 . It promoted cell growth at low concentrations, induced myocardial cell differentiation at medium-range concentrations and caused cell death at higher concentrations. The results in Fig. 7 show that 1 ng/well (0.83 ng/ml) of the medaka activin A 2 can induce ~300 contracting loci, whereas 3 ng/well (2.5 ng/ml) of human activin A can induce ~200 contracting loci. Microscopic observations of cultured cells incubated with human activin A showed them to have morphological appearances indistinguishable from those of cells induced with CM-1 or purified medaka activin A 2 .
Then we performed molecular identification of the cardiomyocytes induced by human activin A. amount of activity that induces one contracting locus in a well. Using these procedures, the cardiac cellinducing factor was purified by 523,100-fold with 8% protein recovery from CM-1 (Table 1 ). The molecular mass of the factor was estimated to be 24-28 kDa by Sephadex G-75 column chromatography (data not shown). Fig. 6 shows a final result of SP-sepharose column chromatography. The activity was detected as a discrete peak at approximately 40 mmol/L NaCl. For determination of the amino-acid sequence of this factor, the purified protein was digested by trypsin and separated peptides were analyzed by a mass spectrometer (Ultraflex MALDI LIFT TOF/TOF MS, Brukar Daltonics K. K.). Peptide mass fingerprint (PMF) data identified the factor as inhibin βA 2 subunit (EMBL/GenBank/DDJB accession no. AB009408) (Tada et al., 1998) . Inhibin is composed of two peptides, α and β subunits, and activin is a homodimer of inhibin β subunits. Since only the inhibin βA 2 subunit was detected, we conclude that the purified cardiac cell-inducing factor is the medaka activin A 2 (βA 2 homodimer). Fig. 7A shows the dose-dependent ef-medium (CM-1), many cells differentiated into rhythmically contracting cells. These cells were characterized as cardiomyocytes. Development of heart has been shown in in vitro cultures of avian (Sugi and Lough, 1995; Schultheiss et al., 1995; Lough et al., 1996; Yatskievych et al., 1997; Ladd et al., 1998; Lough and Sugi, 2000; Barron et al., 2000; Yutzey and Kirby, 2002) and amphibian (Ariizumi et al., 2003) embryo explants. In most of these cases, the cells develops into complex structures containing different tissue lineages. In contrast to these results, our study showed that dissociated medaka blastomeres incubated with CM-1 formed monolayer colonies and differentiated into spontaneously contracting cells (Fig. 2) . This induction of cardiac differentiation is highly reproducible and the ratio of cardiomyocytes is about 30-40% of the surviving cells as judged by microscopic observation of the intact and immuno-stained cells. Differentiation of myocardial cells was the most significant event in this culture system. The rest of the culture was composed of epithelial or spindle-shaped cells. In some cases, a small number of notochord cells (less than 5% of survived cells) which were composed of typical vacuolized cells, were formed. However, these appeared without CM-1, and addition of CM-1 decreased their number, so that differentiation of notochord occurred spontaneously and was not dependent on the factor in the conditioned medium.
Identification of the factor as activin A 2
Through successive protein fractionation steps beginning with a large quantity of the conditioned medium, we succeeded in human activin A confirmed an effect of activin on the differentiation of cardiomyocytes (Figs. 7B, 8, 9 ).
Differentiation of cardiomyocytes by activin A 2
The roles of activins in mesoderm induction and axis formation during the early stages of development have been studied in amphibian embryos (Asashima, 1994; Ariizumi and Asashima, 2001; Sedohara et al., 2006) . Activin was found to induce a broader range of tissues, from ventral to dorsal types, in a gradient fashion depending on its concentration. For example, in the animal cap assay using Xenopus embryos, activin induced ventral types of mesoderm tissue at a low concentration, muscle and neural tube at a middle range of concentration, and dorsal mesoderm, such as notochord, at a high concentration (Asashima, 1994) . Activin A was also shown to induce heart tissues in Xenopus (Ariizumi et al., 2003) and newt (Cynops pyrrhogaster) (Asashima et al., 2000) animal caps at a high concentration (10-1,000 ng/ml). In our study, it was interesting that differentiation of cardiomyocytes occurred at much lower concentrations of activin A 2 compared with those reported with amphibian embryos. In our study, the most efficient amount for the differentiation of cardiomyocytes was at 0.83 ng/ml of medaka activin A 2 or 2.5 ng/ml of human activin A.
The involvement of activins in mesoderm induction in medaka embryos was shown by Wittbrodt and Rosa (1994) . They demonstrated that only maternally provided activin protein is required for the formation of mesoderm and body axis by inhibiting the 
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purifying the cardiomyocyte-inducing factor as a single peak. Analysis of the amino-acid sequences of trypsinized peptide fragments using a mass spectrometer revealed that the factor was medaka activin A 2 .
When the purified protein fraction was added to cultured medaka embryonic cells, it showed the same dose-dependent effects on cell growth and differentiation as the conditioned medium (Fig. 7A) , and differentiated cell morphologies were indistinguishable from those formed with CM-1. Thus, the effect of myocardial cell differentiation induced by CM-1 was attributed solely to activin A 2 . In addition, experiments with expression of zygotically transcribed activins. They also described a temporal difference in the zygotic expression of medaka activins. Activin B mRNA first appears in the late blastula, while transcripts of activin A 1 and A 2 were detected in the late gastrula. In this study, we showed that activin A 2 induces cardiomyocytes in cultured medaka embryonic cells at high frequency. We consider from our results that activin A 2 may have a specific role in the induction of heart in vivo. The temporal difference in the expression of activins (Wittbrodt and Rosa, 1994) may be related to functional differences in development. The possibility of a direct function of medaka activin A 2 in the differentiation of cardiomyocytes in vivo needs to be clarified by further investigation.
Materials and Methods
Cell culture
From the blastula-stage (stage 10-11) (Iwamatsu, 2004 ) medaka embryos, blastoderms were excised and were dissociated to single cells (Hyodo et al., 1998) . The 199ES2 medium was used for cell culture which contained 199 medium (Nissui Seiyaku Co.) supplemented with 20 mmol/ L HEPES (pH 7.5), 50 nmol/L 2-mercaptoethanol, 1 mmol/L sodium pyruvate and 15% fetal calf serum (Hyclone Co.). The cell suspension was transferred to 0.1% gelatin-coated 24-well plates (Nalge Nunc Int.). Cells from 20 embryos were incubated in a well with 1.2 ml of 199ES2 medium containing a conditioned medium or a fractionated protein. The plates were incubated at 28 o C.
To assay their activity during protein fractionation steps, one unit was defined as the amount of activity that induces one contracting locus in a well. Recombinant human activin A (R&D Systems, Inc.) was prepared as a 10 µg/ml stock solution according to recommendation of the supplier.
Conditioned medium
A medaka cell line (MR1) (Hyodo et al., 1998) was used as feeder cell for the conditioned medium (CM-1). This fibroblastic cell line was derived from 5-day-old medaka embryos and was serially transferred in every 7-10 days for more than 5 years. To prepare CM-1, approximately 1X10 6 cells were incubated with 5 ml of the culture medium in a culture flask (25cm 2 , Nalge Nunc Int.). After incubation at 28 o C for 5 days, the culture medium was collected and passed through a 0.2 µm membrane filter. A large scale culture was carried out in a 185 cm 2 culture flask (Nalge Nunc Int.) with 60 ml of culture medium.
Immunostaining
For immuno-histochemical study, cells dissociated from 50-60 embryos were cultured in a glass chamber slide (Nalge Nunc Int.) with 2.2 ml of 199ES2 medium containing 80 µl of CM-1. After 5 days of incubation, cells were fixed in 4% paraformaldehyde in phosphate-buffered saline (PBS) for 30 min at room temperature and rinsed with PBS. The cells were permeabilized by freezing and thawing, and incubated overnight at 4 o C with an anti-troponin I antibody (monoclonal mouse anti-troponin I, bovine cardiac muscle, Advanced ImmunoChem. Inc.) at a dilution of 1:1,000. The secondary antibody was peroxidase-linked sheep anti-mouse IgG (Amersham Biosci. Co.) at a dilution of 1:100. The cells were stained in diamiobenzidine (DAB) solution (50 mM Tris-HCl, pH 7.6, 0.2 mg/ml DAB, 0.65 mg/ml NaN 3 , and 0.5% H 2 O 2 ) for 3-5 min at room temperature and then in a hematoxylin solution for 10 sec.
Electron microscope
For transmission electron microscopy, cells were fixed in 2.5% glutaraldehyde in 50 mmol/L phosphate buffer (pH 7.4) at 4 o C for 1 h, postfixed in 1% OsO4 in the same buffer for 1 h, dehydrated in a graded ethanol series, and embedded in Quetol-812. Thin sections were used for staining with uranylacetate and lead solution, and then observed with an electron microscope 1200EX (JEOL Ltd).
RT-PCR
Total RNA was extracted using Trizol reagent (GIBCO) and RT-PCR was performed. At least three replicate experiments were performed for each time point. One µg of total RNA was reverse-transcribed by SuperScript II reverse-transcriptase (Invitrogen Life Technologies) using an oligo(dT) primer. RT reactions were carried out according to the manufacturer's protocol. The resulting RT reaction mixture was diluted five-fold, and 2 µl was used as template in RT-PCR reactions. PCR was performed for 35 cycles, with each cycle consisting of 94 o C for 30 sec, 55 o C for 40 sec and 72 o C for 1 min, with additional 7 min incubation after completion of the last cycle. We used the following primers to detect these transcripts:
Nkx2.5 -forward:
5'-TTCTCTCAGGCGCAGGTGTACGAGC -3' Nkx2.5 -reverse:
5'-GCAGGGTAGGCGTTGTA -3' 
amhc -forward:
5'-ATGATGGCIGAGGAGCTGAAGAA -3' amhc -reverse:
5'-GGTCATGATGTTCTTGTCGTAGTAG -3' mhc1 -forward:
5'-GGAGCTGGATGATGTGGTTTC -3' mhc1 -reverse:
5'-CATGGGCTAAGGCGTTCTTGGC -3' cmlc2 -forward:
5'-AATGTCTTTTCCATGTTCGAAC -3' cmlc2 -reverse:
5'-CTCCTCTTTCTCAATCACCATG -3' EF-1α -forward:
5'-ATCGTTGCTGCTGGTGTTG -3' EF-1α -reverse:
5'-AGGCGATGTGAGCTGTGTG -3'
Nkx2.5 is a cardiac specific homeobox gene. Atrium myosin heavy chain (amhc) is expressed specifically in atrium cardiomyocytes, and myosin heavy chain1 (mhc1) is specific for ventricle cardiomyocytes. Cardiac myosin light chain2 (cmlc2) is expressed in both atrium and ventricle. (Kudo, A. and Kawakami, A., personal communication) . Amplification of elongation factor-1α (EF-1α) was used in all experiments as a positive control to ensure the quality of the mRNA.
Action potential recording
Electrophysiological studies were performed in 199 medium containing 1.8 mmol/L CaCl 2 , 5.37 mmol/L KCl, and 25 mmol/L HEPES (pH 7.4). A Culture dish was placed on a stage of an inverted phase contrast microscope (IX-70, Olympus) at 20 o C. Action potentials were recorded using a conventional glass microelectrode filled with 3 mol/L KCl and having a DC resistance of 15-30 MΩ. Intracellular recordings were made from 2-week cultured cells. Membrane potentials were measured by means of the current clamp mode (MEZ-8300, Nihon Kohden) with a builtin 4-pole Bessel filter set at 1 kHz.
Pharmacological responses
Phenylephrine (an α 1 -adrenergic receptor agonist; Sigma p-6126), isoproterenol (a β 1 -adrenergic receptor agonist; Sigma I-2760), clenbuterol (a β 2 -adrenergic receptor agonist; Sigma C-5423) and diltiazem (a calcium channel blocker; Sigma D-2521) were used to study pharmacological responses of the spontaneously contracting cells. These reagents were dissolved in dimethyl sulfoxide at high concentrations and 1 µl solution was added to each culture medium. Final concentrations were as indicated in Fig. 5 .
Purification and characterization of the protein factor
Solid ammonium sulfate was added to ten liters of CM-1 until 50% saturation was reached. The mixture was centrifuged at 13,500Xg for 20 min and the precipitate was dissolved in a 20 mmol/L Tris-HCl buffer (pH 7.5, basal buffer). The solution was extensively dialyzed against the basal buffer and then centrifuged as described above. The supernatant was applied to a SP-Sephadex column (5.6X7 cm, Amersham Bioscience Co.) previously equilibrated with the basal buffer. The column was washed with the basal buffer containing 20 mmol/L NaCl. Proteins with cardiac cell-inducing activity were eluted using the basal buffer containing 100 mmol/L NaCl. The active fractions were pooled and solid ammonium sulfate was added to 50% saturation. Then, the precipitate was collected by centrifugation, dissolved in basal buffer and applied to a Sephadex G-75 column (3.6X90 cm, Amersham Bioscience Co.) previously equilibrated with basal buffer containing 0.5 mol/L NaCl. The activity was eluted as a single peak at a position corresponding to a molecular weight of 24-28 kDa. The collected fractions were concentrated using Vivaspin 20 columns (10,000 MWCO PES, VIVASCIENCE), and applied to a hydroxylapatite column (1.0X1 cm, Bio-Gel http Gel, Bio-Lad Laboratories). The column was washed with a 50 mmol/L potassium phosphate buffer (KPB, pH 7.15) and proteins were eluted with a linear gradient of 50-150 mmol/ L KPB at a flow rate of 0.5 ml/min.
The active fractions from three runs of hydroxylapatite column chromatography were collected and concentrated using Vivaspin columns. The concentrated solutions were dialyzed against basal buffer and then applied to an HPLC SP-Sepharose FF column (0.5X1 cm, Amersham Bioscience Co.), which had been equilibrated with the same buffer. After the column was washed with 10 ml of the same buffer, proteins adsorbed to the column were eluted with a linear gradient of 0-100 mmol/L NaCl in basal buffer at a flow rate of 0.5 ml/min. The proteins from the peak fraction were digested with trypsin and analysed using an Ultraflex TOF/ TOF mass spectrometer (Brukar Daltonics K. K.).
Statistics
Data are expressed as mean±SE. Statistical discriminations were performed with Student's t test with P < 0.05 considered significant.
